Strategic Sequencing and Biomarker-Driven Therapy in HR+ Metastatic Breast CancerDanielle Roman, PharmD, BCOP, FHOPA
Neuro-Oncology: Updates in GliomasEdward Lee, PharmD, BCOP
Sara Scott, PharmD, BCOP
Resident Clinical Pearls Implementation of DPYD Pharmacaogenomic Testing and Dose Adjustments; Revumenib vs. Ziftomenib in NPM1-mutated AMLMarina Samuel, PharmDThomas Bokinz, PharmD
The New York State Council of Health-System Pharmacists